Xiaoguang Hao

974 total citations
24 papers, 511 citations indexed

About

Xiaoguang Hao is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Xiaoguang Hao has authored 24 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Xiaoguang Hao's work include Glioma Diagnosis and Treatment (6 papers), Cancer Research and Treatments (3 papers) and Epigenetics and DNA Methylation (3 papers). Xiaoguang Hao is often cited by papers focused on Glioma Diagnosis and Treatment (6 papers), Cancer Research and Treatments (3 papers) and Epigenetics and DNA Methylation (3 papers). Xiaoguang Hao collaborates with scholars based in China, Canada and United States. Xiaoguang Hao's co-authors include Samuel Weiss, H. Artee Luchman, Stephen M. Robbins, Donna L. Senger, Asma M. Aman, Danielle Bozek, Xueqing Lun, J. Gregory Cairncross, Weijing Li and Natalie Grinshtein and has published in prestigious journals such as Nature Communications, Biomaterials and Cancer Research.

In The Last Decade

Xiaoguang Hao

22 papers receiving 508 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoguang Hao China 10 296 128 119 97 52 24 511
Jason M. Beckta United States 10 366 1.2× 108 0.8× 195 1.6× 76 0.8× 59 1.1× 27 544
Parvinder Hothi United States 11 280 0.9× 149 1.2× 147 1.2× 152 1.6× 83 1.6× 14 508
Shabierjiang Jiapaer Japan 9 270 0.9× 160 1.3× 66 0.6× 154 1.6× 41 0.8× 12 456
Joanna Triscott Canada 10 351 1.2× 159 1.2× 113 0.9× 118 1.2× 39 0.8× 15 537
Erika Durinikova Slovakia 12 220 0.7× 85 0.7× 206 1.7× 132 1.4× 47 0.9× 17 477
Sang Kyun Lim United States 8 405 1.4× 110 0.9× 160 1.3× 163 1.7× 54 1.0× 10 563
Vadim Le Joncour Finland 15 296 1.0× 84 0.7× 222 1.9× 74 0.8× 79 1.5× 32 655
Uday Bhanu Maachani United States 13 257 0.9× 149 1.2× 108 0.9× 73 0.8× 45 0.9× 20 533
Tor‐Christian Johannessen Norway 8 350 1.2× 175 1.4× 127 1.1× 145 1.5× 34 0.7× 10 483
Uroš Rajčević Slovenia 11 281 0.9× 110 0.9× 121 1.0× 103 1.1× 37 0.7× 20 491

Countries citing papers authored by Xiaoguang Hao

Since Specialization
Citations

This map shows the geographic impact of Xiaoguang Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoguang Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoguang Hao more than expected).

Fields of papers citing papers by Xiaoguang Hao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoguang Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoguang Hao. The network helps show where Xiaoguang Hao may publish in the future.

Co-authorship network of co-authors of Xiaoguang Hao

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoguang Hao. A scholar is included among the top collaborators of Xiaoguang Hao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoguang Hao. Xiaoguang Hao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Jifang, Xiaoguang Hao, Chuanmin Hu, et al.. (2025). Radical-mediated Cα-Cβ cleavage by ZnIn2S4-based heterojunction materials in photo-electro-catalysis. Journal of Catalysis. 448. 116189–116189.
2.
3.
Hao, Xiaoguang, et al.. (2023). Epigenetic and molecular coordination between HDAC2 and SMAD3-SKI regulates essential brain tumour stem cell characteristics. Nature Communications. 14(1). 5051–5051. 11 indexed citations
4.
Hao, Xiaoguang, Danielle Bozek, Sophia M. Blake, et al.. (2022). BI-907828, a novel potent MDM2 inhibitor, inhibits glioblastoma brain tumor stem cells in vitro and prolongs survival in orthotopic xenograft mouse models. Neuro-Oncology. 25(5). 913–926. 20 indexed citations
5.
Li, Weijing, et al.. (2021). Effects of anesthetic agents on inflammation in Caco‑2, HK‑2 and HepG2 cells. Experimental and Therapeutic Medicine. 21(5). 487–487. 2 indexed citations
6.
Hao, Xiaoguang & Weijing Li. (2021). Chloroquine diphosphate suppresses liver cancer via inducing apoptosis in Wistar rats using interventional therapy. Oncology Letters. 21(3). 233–233. 4 indexed citations
7.
Hao, Xiaoguang & Weijing Li. (2021). Molybdenum Dioxide (MoS2)/Gadolinium (Gd) Containing Arginine-Glycine-Aspartic Acid (RGD) Sequences as New Nano-Contrast Agent for Cancer Magnetic Resonance Imaging (MRI). Journal of Nanoscience and Nanotechnology. 21(3). 1403–1412. 7 indexed citations
8.
9.
Rahn, Jennifer J., Xueqing Lun, Selina K. Jorch, et al.. (2020). Development of a peptide-based delivery platform for targeting malignant brain tumors. Biomaterials. 252. 120105–120105. 16 indexed citations
10.
Hao, Xiaoguang, et al.. (2020). EGFR blockade in GBM brain tumor stem cells synergizes with JAK2/STAT3 pathway inhibition to abrogate compensatory mechanisms in vitro and in vivo. Neuro-Oncology Advances. 2(1). vdaa020–vdaa020. 22 indexed citations
11.
MacLeod, Graham, Danielle Bozek, Nishani Rajakulendran, et al.. (2019). Genome-Wide CRISPR-Cas9 Screens Expose Genetic Vulnerabilities and Mechanisms of Temozolomide Sensitivity in Glioblastoma Stem Cells. Cell Reports. 27(3). 971–986.e9. 144 indexed citations
12.
Luchman, H. Artee, Danielle Bozek, Xiaoguang Hao, et al.. (2019). Abstract 3084: BI-907828: A novel, potent MDM2 inhibitor, inhibits GBM brain tumor stem cells in vitro and prolonged survival in orthotopic xenograft mouse models. Cancer Research. 79(13_Supplement). 3084–3084. 1 indexed citations
13.
Jiang, Bin, Xueqing Lun, Xiaoguang Hao, et al.. (2017). Temozolomide resistant human brain tumor stem cells are susceptible to recombinant vesicular stomatitis virus and double-deleted Vaccinia virus in vitro. Biomedicine & Pharmacotherapy. 95. 1201–1208. 11 indexed citations
14.
Bozek, Danielle, et al.. (2017). STEM-28. DOT1L EPIGENETICALLY REGULATES GBM BRAIN TUMOR STEM CELLS. Neuro-Oncology. 19(suppl_6). vi231–vi232. 2 indexed citations
15.
Lun, Xueqing, J. Connor Wells, Natalie Grinshtein, et al.. (2016). Disulfiram when Combined with Copper Enhances the Therapeutic Effects of Temozolomide for the Treatment of Glioblastoma. Clinical Cancer Research. 22(15). 3860–3875. 169 indexed citations
16.
Yang, Bao, et al.. (2016). Correlation between chromosome 1p/19q status and VEGF mRNA expression in gliomas. Genetics and Molecular Research. 15(1). 2 indexed citations
17.
Ahn, Bo Young, Roberta Saldanha-Gama, Jennifer J. Rahn, et al.. (2015). Glioma invasion mediated by the p75 neurotrophin receptor (p75NTR/CD271) requires regulated interaction with PDLIM1. Oncogene. 35(11). 1411–1422. 37 indexed citations
18.
Li, Xiuling, Xin Ye, Jun Wang, et al.. (2014). Chemical ablation therapy of recurrent mediastinal nodal metastasis in post-radiotherapy cancer patients. Medical Oncology. 31(10). 224–224. 1 indexed citations
19.
Wang, Yihua, Cuiping Zhao, Xiaoguang Hao, Chengwei Wang, & Zhigang Wang. (2014). Endovascular interventional therapy and classification of vertebral artery dissecting aneurysms. Experimental and Therapeutic Medicine. 8(5). 1409–1415. 9 indexed citations
20.
Yu, Wenbin, Feng Li, Zhigang Wang, et al.. (2010). Effects of CO2 insufflation on cerebrum during endoscopic thyroidectomy in a porcine model. Surgical Endoscopy. 25(5). 1495–1504. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jason M. Beckta Breakdown of academic impact, for papers by Parvinder Hothi Breakdown of academic impact, for papers by Shabierjiang Jiapaer Breakdown of academic impact, for papers by Joanna Triscott Breakdown of academic impact, for papers by Erika Durinikova Breakdown of academic impact, for papers by Sang Kyun Lim Breakdown of academic impact, for papers by Vadim Le Joncour Breakdown of academic impact, for papers by Uday Bhanu Maachani Breakdown of academic impact, for papers by Tor‐Christian Johannessen Breakdown of academic impact, for papers by Uroš Rajčević
Rankless by CCL
2026